- Home
- TRAW
TRAW
TRAWS PHARMA INC
as 07-26-2024 4:00pm EST
Stocks
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | NEWTOWN |
| Market Cap: | 11.4M | IPO Year: | 2013 |
| Target Price: | N/A | AVG Volume (30 days): | 103.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.87 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.33 - $1.10 | Next Earning Date: | 08-16-2024 |
| Revenue: | $226,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | -9.73% | Revenue Growth (next year): | 50.00% |
Latest TRAWS PHARMA INC News
TRAW Breaking Stock News: Dive into TRAW Ticker-Specific Updates for Smart Investing
Newsfile
2 months ago
Edge Total Intelligence Inc. Updates Status of MCTO
GlobeNewswire
2 months ago
LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting
GlobeNewswire
2 months ago
Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers
GlobeNewswire
2 months ago
The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024
CNW Group
2 months ago
Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
GlobeNewswire
2 months ago
Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
CNW Group
2 months ago
HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
PR Newswire
2 months ago
IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
Compare TRAW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TRAW TRAWS PHARMA INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.